Pro: I would start therapy in an asymptomatic patient with mild systemic sclerosis-associated ILD - Vienna 2024

Should connective tissue-related interstitial lung diseases be treated at the earliest opportunity?

Chair(s): Michael Kreuter, Nazia Chaudhuri

Session type: Pro-Con debate

Pro: I would start therapy in an asymptomatic patient with mild systemic sclerosis-associated ILD

Vanessa Smith

EVENTS HOME

Replay
Slides

Previous presentation

Next presentation

Session content

Pro: I would start therapy in an asymptomatic patient with mild systemic sclerosis-associated ILD

Vanessa Smith

Replay

Slides

Con: I would not start therapy in an asymptomatic patient with mild systemic sclerosis-associated ILD

Paolo Spagnolo

Replay

Slides

Discussion and Q&A

Replay

Session aims

To highlight some of the emerging themes and controversies regarding the early treatment of interstitial lung diseases; to discuss the common clinical dilemmas and misconceptions that occur in clinical practise regarding the influence of age and comorbidities on the decision to start anti-inflammatory or antifibrotic treatment; to explore the role of risk stratification and early treatment in connective tissue diseases.

CDN Connection Issue

The ERS Congress 2024, Vienna

#{title}